These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 745806)

  • 21. [Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
    Halvorsen S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2829-32. PubMed ID: 10494205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of balneotherapeutic measures on blood rheologic parameters in patients with atherosclerosis].
    Winkler R; Klieber M
    Wien Klin Wochenschr; 1986 Aug; 98(15):490-5. PubMed ID: 3765637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proposals for a plan of fibrinolytic-clearing therapy of peripheral obstructive arteriopathy].
    Ferliga G
    G Gerontol; 1967 Aug; 15(8):955-71. PubMed ID: 4181505
    [No Abstract]   [Full Text] [Related]  

  • 24. [The significance of rheologic mechanisms in atherogenesis].
    Leschke M; Strauer BE
    Arzneimittelforschung; 1990 Mar; 40(3A):356-62. PubMed ID: 2185764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of various hemorheological parameters in nonagenarians: evidence of an increase of fibrinogen].
    Armani U; Piana A; Cella A; Gastaldi S; Del Nero E
    Boll Soc Ital Biol Sper; 1990 Oct; 66(10):961-7. PubMed ID: 2096881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regional study of the principal hemorheological factors in peripheral obstructive arteriopathy. I].
    Artale F; Sergio G; Espureo M; Giunti P; Francisci A; Perego MA
    Minerva Cardioangiol; 1981; 29(7-8):367-74. PubMed ID: 7279237
    [No Abstract]   [Full Text] [Related]  

  • 28. [Role of fibrinogen in arterial vascular pathology].
    Colorio CC; Falcón CR; Carreras LO
    Sangre (Barc); 1997 Feb; 42(1):47-52. PubMed ID: 9097719
    [No Abstract]   [Full Text] [Related]  

  • 29. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels with cigarette smokers.
    Dintenfass L
    Med J Aust; 1975 May; 1(20):617-20. PubMed ID: 1143159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic hypertension--the importance of fibrinogen and blood viscosity.
    Feher MD; Rampling MW; Sever PS; Elkeles RS
    J Hum Hypertens; 1988 Aug; 2(2):117-22. PubMed ID: 3244146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The significance of the fibrinogen level and hematocrit for the quantitative determination of cerebral blood flow].
    Vinichuk SM
    Vrach Delo; 1990 May; (5):40-2. PubMed ID: 2396389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen and viscosity: risk factors for cardiovascular events.
    Resch KL; Ernst E
    Compr Ther; 1994; 20(3):170-3. PubMed ID: 8187458
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of 3-glucosaminoglycan sulfate on hemorheologic parameters in hyperlipidemic peripheral vascular disease (PVD) patients: a preliminary double-blind crossover study.
    Ciuffetti G; Mercuri M; Susta A; Lupattelli G; Pasqualini L; Lombardini R; Mannarino E
    Angiology; 1989 Apr; 40(4 Pt 1):255-9. PubMed ID: 2705632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fibrinolytic and defibrinogenation therapy].
    Mannucci PM; Mari D
    Ric Clin Lab; 1983; 13 Suppl 3():245-55. PubMed ID: 6672998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pattern of blood viscosimetric values, fibrinogen, and various glycoproteins in patients with obliterating sclerotic peripheral vascular disease treated with 3GS].
    Sarno A; Bruno S; Romano A; Catania A; la Bruzzo S; Francavilla G; Caimi G
    Clin Ter; 1980 Nov; 95(3):289-95. PubMed ID: 7214844
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemorheologic changes in patients with obliterative arteriopathy of the leg before and after muscle exercise tests].
    Bianco S; Todini AR; Fabiani F; Bartolo M
    J Mal Vasc; 1990; 15(3):291-5. PubMed ID: 2212878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of anticoagulants on blood viscosity].
    Schäbitz J; Petri A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):301-8. PubMed ID: 6194063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influencing the fibrinolytic activity by antithrombotics in patients with atherosclerosis].
    Norden C; Reimann H; Grunow G; Misselwitz F; Taube C; Heine H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):907-13. PubMed ID: 2483710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in blood viscosity with the recombinant tissue plasminogen activator alteplase.
    Hitosugi M; Omura K; Yufu T; Kido M; Niwa M; Nagai T; Tokudome S
    Thromb Res; 2007; 120(3):447-50. PubMed ID: 17064755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.